メニューにジャンプ コンテンツにジャンプ

トップページ > 当センターについて > 業績集 > ACC業績集 2010年

ACC業績集 2010年

英文

ACC Publications 2010

※PubMed等(外部サイト)にリンクします

  1. Tsukada K, Teruya K, Tasato D, Gatanaga H, Kikuchi Y, and Oka S. Raltegravir-associated perihepatitis and peritonitis: a single case report. AIDS (correspondence) 24: 160-161, 2010.
  2. Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H, Takiguchi M, and Oka S. Impact of HLA-B*51-restricted CTL Pressure on Mutation Patterns of Non-nucleoside Reverse Transcriptase Inhibitor Resistance. AIDS (Fast Track) 24: F15-22, 2010.
  3. Sakai K, Gatanaga H, Takata H, Oka S, and Takiguchi M. Comparison of CD4+ T-cell-subset distribution in chronically infected HIV+ patients with various CD4 nadir counts. Microb Infect 12: 374-381, 2010, Epub 2010 Jan 29.
  4. Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H, Oka S. Combination of V106I and V179D Polymorphic Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Efavirenz and Nevirapine but not to Etravirine. Antimicrob Agents Chemother 54: 1596-1602, 2010, Epub 2010 Feb 1.
  5. Phan TT, Ishizaki A, Phung DC, Bi X, Oka S, and Ichimura H. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam. AIDS Res Hum Retroviruses 26: 233-235, 2010.
  6. Koizumi H, Hashimoto M, Fujiwara M, Chikata T, Borghan MA, Hachiya A, Kawashima Y, Takata H, Ueno T, Oka S, and Takiguchi M. Different in vivo effects of HIV-1 immunodominant epitope-specific CTLs on selection of escape mutant viruses. J Virol 84: 5508-5519, 2010, Epub 2010 Mar 24.
  7. Kawashima Y, Kuse N, Gatanaga H, Naruto T, Fujiwara M, Dohki S, Maenaka K, Goulder P, Oka S, and Takiguchi M. Long-term control of HIV-1 by HIV-1 pol-specific CTLs in hemophiliacs carrying slow-progressing allele HLA-B*5101. J Virol 84: 7151-7160, 2010, Epub 2010 April 21.
  8. Gatanaga H, Oowa M, and Oka S. Introduction of TaqMan HIV-1 assay increased unnecessary drug resistance testing. AIDS Patient Care (Letter to the Editor) 24: 1-2, 2010.
  9. Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol 82: 1355-1363, 2010.
  10. Takarabe D, Rokukawa Y, Takahashi Y, Goto A, Takaichi M, Okamoto M, Tsujimoto T, Noto H, Kishimoto M, Kaburagi Y, Yasuda K, Yamamoto-Honda R, Tsukada K, Honda M, Teruya K, Kajio H, Kikuchi Y, Oka S, Noda M. Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy. J Clin Endocrinol Metab 2010 May 19. [Epub ahead of print]
  11. Tanuma J, Hachiya A, Ishigaki K, Gatanaga H, Lien TTM, Hien ND, Kin NV, Kaku M, and Oka S. Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors. Microb Infect 12: 1170-1177, 2010.
  12. Hattori J, Shiino T, Gatanaga H, Yoshida S, Watanabe D, Minami R, Sadamasu K, Kondo M, Mori H, Ueda M, Tateyama M, Ueda A, Kato S, Ito T, Oie M, Takata N, Hayashida T, Nagashima M, Matsuda M, Ibe S, Ota Y, Sasaki S, Ishigatsubo Y, Tanabe Y, Koga I, Kojima Y, Yamamoto M, Fujita J, Yokomaku Y, Koike T, Shirasaka T, Oka S, and Sugiura W. Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res 88: 72-79, 2010.
  13. Nakamura H, Teruya K, Takano M, Tsukada K, Tanuma J, Yazaki H, Honda H, Honda M, Gatanaga H, Kikuchi Y, and Oka S. Clinical symptoms and courses of primary HIV-1 infection in recent years in Japan. Intern Med 50: 95-101, 2011.
  14. Honda M, Ishisaka M, Ishizuka N, Kimura S, Oka S on behalf of Japanese Anti-HIV-1 QD Study Group. Open-label randomized multicenter selection study of once daily antiretroviral treatment regimen comparing ritonavir boosted atazanavir to efavirenz with fixed dose abacavir and lamivudine. Intern Med (in press)
  15. Watanabe T, Murakoshi H, Gatanaga H, Koyanagi M, Oka S, and Takiguchi M. Effective recognition of HIV-1-infected cells by HIV-1 Integrase-specific HLA-B*4002-restricted T cells. Microb Infect 13: 160-166, 2011.
  16. Mwimanzi P, Hasan Z, Tokunaga M, Gatanaga H, Oka S, and Ueno T. Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection. Biochem Biophys Res Commun 2010 Nov 17. [Epub ahead of print]

和文

準備中

国際学会

準備中

国内学会

準備中